Table 3. Revised recommendation levels.

Levels of evidence of the 2011 guideline		Revised evidence level
1	Evidence from at least one randomized controlled trial	High
2	Evidence from a well-designed clinical study, albeit not a randomized trial	Moderate
3	Expert opinions based on clinical experiences or committee reports	Very Low